U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153991) titled 'Efficacy of Donepezil in Patients With Chronic Tinnitus' on Aug. 20.
Brief Summary: This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.
Study Start Date: Nov. 19, 2021
Study Type: INTERVENTIONAL
Condition:
Tinnitus
Intervention:
DRUG: Donepezil group
Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg dail...